Why Chemed Corporation (CHE) stock moved
Chemed Corporation (CHE) shares fell 1.0% to $543.19 as of August 27, 2026, a slight decline from the prior close of $548.56. BestStocks flagged the session as a major change for CHE. No single company-specific catalyst was confirmed during the move window. Below, we break down what changed for CHE, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
CHE fell 1.0% to $543.18
Chemed Corporation (CHE) moved -2.63% from $551.65 to $537.14 on 2026-08-11. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, suggesting a routine pullback rather than a reaction to major news. CHE earnings are scheduled for 2026-10-27, with consensus EPS estimate of $6.48.
What it means for Chemed Corporation investors
For Chemed Corporation investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive price momentum; Chemed Corporation (CHE) moved +0.72% from $510.03 to $513.68 on 2026-07-20. Weighing against that: Negative session, down 1.0%; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $554.00, implying +2.0% upside from $543.19. BestStocks rates the overall signal quality weak (22/100). With earnings roughly 61 days out, the next report is the most likely near-term test of the move.
CHE price reaction
CHE last traded at $543.19, down $5.38 (-0.98%) from the previous close of $548.56. The session traded on 0.3× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $509.34 and $552.72, and it currently sits about 78% of the way up that band.
Bullish and bearish analyst opinions on Chemed Corporation (CHE)
The consensus analyst price target on Chemed Corporation (CHE) is $554.00, 2.0% above the recent $543.19. Over the past 90 days analysts logged 0 upgrades, 3 maintains, and 0 downgrades. Here is how the bullish and bearish cases on CHE line up.
The bullish case
- Wall Street's consensus price target of $554.00 implies +2.0% upside from $543.19.
- The Street's most bullish target is $633.00 (+16.5%).
- Positive price momentum.
- Chemed Corporation (CHE) moved +0.72% from $510.03 to $513.68 on 2026-07-20.
The bearish case
- The most bearish analyst target is $475.00 (-12.6%).
- Negative session, down 1.0%.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Aug 27, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for CHE
Frequently asked questions about CHE
Why did Chemed Corporation (CHE) stock move?
CHE fell 1.0% to $543.19. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did CHE stock fall?
CHE lost 0.98% ($5.38) versus the prior close of $548.56, last trading at $543.19 on 0.3× average volume.
When is Chemed Corporation's next earnings date?
CHE's next earnings report is estimated for 2026-10-27 — about 61 days away.
What is the analyst price target for CHE?
The consensus analyst price target for CHE is $554.00, about 2.0% above the current $543.19. Over the past 90 days, analysts recorded 0 upgrades, 3 maintains, and 0 downgrades.
How BestStocks tracks CHE
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared CHE-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for CHE, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of August 27, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.